Kaisheng New Materials
Shandong Kaisheng New Materials is a Chinese public company (SZSE: 301069) producing fine chemicals and PEKK (polyetherketoneketone) resin, expanding PEKK use into aerospace, medical implant, and additive manufacturing applications.
- CEO / Founder
- Wang Jiarong (王加荣)
- Team Size
- 501-1000
- Stage
- Public
- Total Funding
- $140M
- Latest Round
- Post-IPO
Technology & Products
Key Products
PEKK resin and pellets; aramid polymerization monomers (isophthaloyl chloride, terephthaloyl chloride); thionyl chloride; other chlorinated fine chemicals; new lithium salt materials for batteries.
Technological Advantage
Proprietary one-step PEKK synthesis route; vertically integrated chlorinated fine-chemical and aramid monomer production feeding PEKK value chain; domestic leadership in thionyl chloride and aromatic polyamide monomers.
Differentiation
Value Proposition
Domestic first-mover in mass-produced PEKK resin via a proprietary one-step synthesis process claimed to offer a cost advantage over established Western PEKK suppliers, now extending into high-temperature, high-strength applications for aerospace brackets, medical implants, and SLS additive manufacturing.
How They Differentiate
Claims a lower-cost one-step PEKK synthesis process versus multi-step routes used by Western incumbents, backed by existing scale in adjacent chlorinated fine chemicals; has not yet confirmed qualified spherical PEKK powder for SLS.
Market & Competition
Target Customers
Downstream manufacturers in aerospace, medical device, aramid fiber, lithium battery, and specialty chemical industries; early-stage AM material test customers.
Industry Verticals
Aerospace, Medical Devices, Additive Manufacturing, Lithium Battery, High-Performance Fibers (Aramid), Agrochemicals, Food Additives
Competitors
Arkema (Kepstan PEKK); Victrex; Oxford Performance Materials
Growth & Milestones
Growth Metrics
2023 revenue ¥987M, total assets ¥2.48B, debt-to-asset ratio below 16.87%; R&D spend ¥53.8M (2024) vs ¥51.5M (2023); 2025 net profit up 129% YoY per 2025 annual report; ~868 employees.
Major Milestones
Founded Dec 2005; became China's first company to achieve PEKK mass production; IPO on Shenzhen ChiNext Sept 2021 raising ¥310.2M (stock code 301069.SZ); issued ¥650M convertible bonds Nov-Dec 2023 for a new lithium-salt project; re-elected Chairman Wang Jiarong to 4th Board term June 2025-2028; in a Sept 2026 shareholder Q&A confirmed optimization of one-step PEKK synthesis and shipment of test samples to aerospace/medical/AM customers, while vertical integration into spherical SLS powder remains unconfirmed.
Notable Customers
DuPont, Teijin, Taihe New Material (aramid monomer customers); undisclosed aerospace, medical, and additive-manufacturing customers received PEKK test samples per company investor disclosure.